Aeterna Zentaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Outlook : vimarsana.com

Aeterna Zentaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Outlook

– Continue to advance and expand opportunities with established diversified development pipeline – Company ended the year with $65.3 million in cash,…

Related Keywords

Germany , Australia , United States , United Kingdom , Massachusetts , Boston , Bulgaria , Canada , Russia , Toronto , Ontario , South Korea , Turkey , Ukraine , Russian , Republic Of Korea , America , Canadian , Lou Gehrig , Jenene Thomas , Thomas Rudel , Joerg Wischhusen , Klaus Paulini , Development Pipeline , Company On Twitter , Linkedin , Aeterna Zentaris , University Of Queensland , Kim Pharmaceuticals Bulgaria , Nk Meditech Ltd , Nasdaq , Aeterna Zentaris Inc , European Union , Facebook , Therapeutics Development Pipeline , University Hospital In Wuerzburg , European Commission , University Of Sheffield , University Of Wuerzburg , Toronto Stock Exchange , Postmedia Network Inc , Diagnostics Development Pipeline , Novo Nordisk , Aeterna Zentaris Reports Fourth Quarter , Full Year , Provides Business Outlook , Chief Executive Officer , Julius Maximilians University Wuerzburg , Giuliano La Fratta , Chief Financial , Clinical Programs Update , University Hospital , Michael Levy , Massachusetts General Hospital , Auto Immunity Modifying Biologicals , Clearance Parathyroid Hormone , Fusion Polypeptides , North America , New Drug Application , Er Kim Pharmaceuticals Bulgaria , Fourth Quarter , Financial Statements , Financial Condition , Litigation Reform Act , Novo Amended License Agreement , Annual Report , Postmedia Network , Street East ,

© 2024 Vimarsana